Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Instanyl for Breakthrough Cancer Pain (FT-017-IM)
NCT00345735Phase 2Completed
- Sponsor
- Nycomed
- Start
- May 2006
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl in breakthrough cancer pain (BTcP), sponsored by Nycomed. Started May 2006; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT00345735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345735.